Recombinant Human CCL25/TECK Protein Summary
Product Specifications
Gln24-Leu150, with an N-terminal Met
Analysis
Product Datasheets
334-TK/CF (carrier free)
Discontinued Product
334-TK
Formulation | Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: CCL25/TECK
CCL25, also known as TECK (thymus-expressed chemokine), is a CC chemokine that regulates the trafficking of lymphocytes in the thymus and small intestine. Mature human CCL25 shares 40% amino acid sequence identity with mouse and rat CCL25 (1). CCL25 is produced by stromal cells in the thymus and epithelial cells of the small intestine, particularly the jejunum and ileum (1-3). It binds to and induces chemoattraction through CCR9 (1, 4, 5), and both human and mouse proteins act on human CCR9 (4). CCR9 is expressed on immature pre-T cells and thymocytes (5, 6). CCL25 induces the homing of several lymphocyte populations to the small intestine (3), including Integrin alpha 4 beta 7+ gamma δ T cells (6, 7), Integrin alpha E beta 7+ CD8+ T cells (8), and IgA-producing plasma cells (2). In cancer, functional CCR9 mediates the metastasis of melanoma cells to the small intestine (9), contributes to the CCL25-dependent migration and invasion of some breast carcinomas (10), and attracts mesenchymal stromal cells to CCL25-expressing multiple myelomas (11). CCL25 contributes to the severity of chronic inflammation in rheumatoid arthritis where it attracts CCR9+ monocytes and macrophages (12), in endometriosis where it promotes the invasiveness of stromal cells (13), and in atherosclerosis where it contributes to the accumulation of CCR9+ macrophages in arterial plaques (14).
- Vicari, A.P. et al. (1997) Immunity 7:291.
- Bowman, E.P. et al. (2002) J. Exp. Med. 195:269.
- Kunkel, E.J. et al. (2000) J. Exp. Med. 192:761.
- Zaballos, A. et al. (1999) J. Immunol. 162:5671.
- Youn, B.-S. et al. (1999) Blood 94:2533.
- Uehara, S. et al. (2002) J. Immunol. 168:134.
- Costa, M.F.S. et al. (2012) Eur. J. Immunol. 42:1250.
- Svensson, M. et al. (2002) J. Clin. Invest. 110:1113.
- Amersi, F.F. et al. (2008) Clin. Cancer Res. 14:638.
- Johnson-Holiday, C. et al. (2011) Int. J. Oncol. 38:1279.
- Xu, S. et al. (2012) Stem Cells 30:266.
- Schmutz, C. et al. (2010) Arthritis Res. Ther. 12:R161.
- Wang, Y. et al. (2010) Cell. Mol. Immunol. 7:51.
- Alla, J.A. et al. (2010) J. Biol. Chem. 285:23496.
Citations for Recombinant Human CCL25/TECK Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
7
Citations: Showing 1 - 7
Filter your results:
Filter by:
-
Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
J. Clin. Invest., 2012-08-06;122(9):3184-96.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Authors: Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J
Nature, 2012-07-26;487(7408):505-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.
Authors: Badr G, Lefevre EA, Mohany M
PLoS ONE, 2011-09-01;6(9):e23741.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells.
Authors: Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH
J. Immunol., 2007-09-15;179(6):3724-33.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Novel antiviral activity of chemokines.
Authors: Nakayama T, Shirane J, Hieshima K, Shibano M, Watanabe M, Jin Z, Nagakubo D, Saito T, Shimomura Y, Yoshie O
Virology, 2006-04-17;350(2):484-92.
Species: Virus
Sample Types: Virus, Whole Cells
Applications: Binding Assay, Bioassay -
Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells.
Authors: Sen Y, Chunsong H, Baojun H, Linjie Z, Qun L, San J, Qiuping Z, Junyan L, Zhang X, Jinquan T
Immunology, 2004-06-01;112(2):274-89.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Expression of functional CCR and CXCR chemokine receptors in podocytes.
Authors: Huber TB, Reinhardt HC, Exner M, Burger JA, Kerjaschki D, Saleem MA, Pavenstadt H
J. Immunol., 2002-06-15;168(12):6244-52.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human CCL25/TECK Protein
There are currently no reviews for this product. Be the first to review Recombinant Human CCL25/TECK Protein and earn rewards!
Have you used Recombinant Human CCL25/TECK Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image